SCHEMBL18663292

SCHEMBL18663292

COC(=O)C1(C(=O)OC)C(c2ccccc2)=C(c2ccc(C(F)(F)F)cc2)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 2/20 0.43
▸ TP53 P04637 3/20 0.41
▸ KIF11 P52732 1/20 0.40
▸ ABCG2 Q9UNQ0 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ FFAR1 O14842 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ MAPT P10636 4/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ APAF1 O14727 1/20 0.36
▸ TDP2 O95551 1/20 0.36
▸ NSD2 O96028 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ GALK1 P51570 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ TACR1 P25103 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18663367 0.85 FGFR1 (0.39) PDK2MAPTKMT2AFGFR1SRC
SCHEMBL19690532 0.84 ALDH1A1 (0.39) PDK2FFAR1FFAR4MAPT
SCHEMBL18663404 0.83 MAPT (0.46) PDK2MAPTFGFR1SRCFGFR2
SCHEMBL19690698 0.77 GAA (0.38) PDK2KDM4EKMT2AFGFR1SRC
SCHEMBL18663293 0.77 SLC6A3 (0.45) PDK2MAPTKDM4EFGFR1SRC
SCHEMBL18663374 0.75 OPRK1 (0.39) PDK2MAPTKDM4EKMT2AFGFR1
SCHEMBL18663359 0.75 ALDH1A1 (0.43) TP53MAPTKDM4EKMT2A
SCHEMBL19690521 0.74 SMN1; SMN2 (0.44) TP53PDK2MAPTKDM4EKMT2A
SCHEMBL18663305 0.72 OPRK1 (0.37) MAPTKDM4EKMT2AFGFR1SRC
SCHEMBL19690413 0.71 SMN1; SMN2 (0.43) TP53PDK2MAPTKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF BEIJING LIHE TECH LTD (CN) 2017-03-30 — — US claimed
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2017-12-14 — — US disclosed
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF BEIJING LIHE TECH LTD (CN) 2017-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF TEC, DGAT2, MOGAT2 BACE1 3278/4885TP53 4095/4885KIF11 3585/4885
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, COG7, COG4 BACE1 1571/4885TP53 3627/4885KIF11 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback